Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  ondansetron hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-10 of 10 for your search:
Start Over
Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-0961, NCI-2012-01557, NCT00542542
A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NKV110721, NCT00601172
Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 20 to 120
Sponsor: Other
Protocol IDs: RMS vs ODS for CRINV, 0808-011-252, NCT00971399
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 21 and over
Sponsor: Other
Protocol IDs: 2247.00, NCI-2010-00325, FHCRC-2247.00, IR-6765, NCT00795769
Ondansetron Versus Aprepitant Plus Ondansetron for Emesis
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2008-0615, NCT00954941
Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NKV101983, NCT00104403
Emend for Multiple-day Emetogenic Chemotherapy
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005-0363, NCT00711555
Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 03-1192, NCT00314743
Ondansetron Plus Dexamethasone With or Without Metoclopramide as Antiemetic Prophylaxis After Receiving Cisplatin
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: Si094/2009, NCT01093690
Start Over